Shimoda Takahiro, Tomida Kouki, Nakajima Chika, Kawakami Ayuka, Shimada Hiroyuki
Department of Preventive Gerontology, Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
Department of Preventive Gerontology, Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
J Am Med Dir Assoc. 2025 Jan;26(1):105356. doi: 10.1016/j.jamda.2024.105356. Epub 2024 Nov 14.
To examine the optimal range of steps for an individual based on the dose-response relationship of the number of steps taken with disability incidence and all-cause mortality stratified by age and physical frailty.
Prospective cohort study.
8664 community-dwelling older adults.
The daily number of steps was measured using an accelerometer. Disability incidence and mortality were prospectively determined over 60 months. Participants were stratified using a nonlinear restricted cubic spline based on age ≥75 or <75 years and physical frailty, per the revised Japanese version of the Cardiovascular Health Study criteria.
The study cohort's median age was 74 years [interquartile range (IQR) range 71-78), and 54.0% were female. Incidental disability and death were observed in 1373 (15.8%) and 529 (6.1%) participants, respectively. The median steps per day were 5514 (IQR 3878-7616). Daily steps were nonlinearly associated with disability incidence and mortality. The optimal cutoff points for frail and nonfrail participants were, respectvely, 2168 [hazard ratio (HR) 0.74, 95% CI 0.56-0.98] and 7459 (HR 0.86, 95% CI 0.74-0.99) steps for disability incidence and 2593 (HR 0.63, 95% CI 0.40-0.98) and 3282 (HR 0.77, 95% CI 0.61-0.98) steps for all-cause mortality. The optimal cutoff points for participants >75 and <75 years were, respectively, 6066 (HR 0.83, 95% CI 0.72-0.99) and 8573 (HR 0.77, 95% CI 0.59-0.99) steps for disability incidence and 1824 (HR 0.67, 95% CI 0.46-0.98) and 4128 (HR 0.72, 95% CI 0.52-0.99) steps for all-cause mortality.
Participants ≥75 years and frail participants required lower daily steps for preventing disability incidence and all-cause mortality than those <75 years and nonfrail participants, indicating that lower targets may still provide health-promoting benefits. Thus, the optimal step number should be considered based on individual characteristics, including age and frailty.
根据步数与残疾发生率及全因死亡率之间的剂量反应关系,按年龄和身体虚弱程度分层,研究个体的最佳步数范围。
前瞻性队列研究。
8664名社区居住的老年人。
使用加速度计测量每日步数。前瞻性地确定60个月内的残疾发生率和死亡率。根据修订后的日本版心血管健康研究标准,基于年龄≥75岁或<75岁以及身体虚弱程度,使用非线性受限立方样条对参与者进行分层。
研究队列的中位年龄为74岁[四分位间距(IQR)范围71 - 78岁],女性占54.0%。分别有1373名(15.8%)和529名(6.1%)参与者发生了意外残疾和死亡。每日步数中位数为5514步(IQR 3878 - 7616)。每日步数与残疾发生率和死亡率呈非线性相关。对于身体虚弱和非虚弱的参与者,残疾发生率的最佳截断点分别为2168步[风险比(HR)0.74,95%置信区间(CI)0.56 - 0.98]和7459步(HR 0.86,95% CI 0.74 - 0.99),全因死亡率的最佳截断点分别为2593步(HR 0.63,95% CI 0.40 - 0.98)和3282步(HR 0.77,95% CI 0.61 - 0.98)。对于年龄>75岁和<75岁的参与者,残疾发生率的最佳截断点分别为6066步(HR 0.83,95% CI 0.72 - 0.99)和8573步(HR 0.77,95% CI 0.59 - 0.99),全因死亡率的最佳截断点分别为1824步(HR 0.67,95% CI 0.46 - 0.98)和4128步(HR 0.72,95% CI 0.52 - 0.99)。
与年龄<75岁且非虚弱的参与者相比,年龄≥75岁的参与者和虚弱的参与者预防残疾发生率和全因死亡率所需的每日步数更低,这表明较低的目标步数仍可能带来促进健康的益处。因此,应根据包括年龄和虚弱程度在内的个体特征来考虑最佳步数。